DesOwen® Cream, Ointment and Lotion are low to medium potency corticosteroids indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

DesOwen® Cream, Ointment or Lotion should be applied to the affected areas as a thin film two or three times daily depending on the severity of the condition. SHAKE LOTION WELL BEFORE USING.

As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary.

DesOwen® Cream, Ointment and Lotion should not be used with occlusive dressings.

DesOwen® (desonide cream) Cream 0.05% is supplied as follows:

60 g tube - NDC 0299-5770-60
60 g tube with complimentary 1 fl oz Cetaphil® Moisturizing Lotion - NDC 0299-5770-01

DesOwen® (desonide ointment) Ointment 0.05% is supplied as follows:

60 g tube - NDC 0299-5775-60
60 g tube with complimentary 1 fl oz Cetaphil® Moisturizing Lotion - NDC 0299-5775-01

DesOwen® (desonide lotion) Lotion 0.05% is supplied as follows:

2 fl oz bottle - NDC 0299-5765-02
2 fl oz bottle with complimentary .5 oz Cetaphil® Moisturizing Cream - NDC 0299-5765-00
4 fl oz bottle - NDC 0299-5765-04
4 fl oz bottle with complimentary .5 oz Cetaphil® Moisturizing Cream - NDC 0299-5765-03

Storage Conditions: Store between 2° and 30°C (36° and 86°F).

Marketed by: GALDERMA LABORATORIES, L.P. Fort Worth, Texas 76177, USA. Mfd. by: DPT Laboratories, Ltd. San Antonio, Texas 78215, USA. Revised: June 2008. FDA Rev date: 06/12/98

Bookmark this page: